Filing Details

Accession Number:
0001622627-25-000010
Form Type:
13G Filing
Publication Date:
2025-02-11 19:00:00
Filed By:
Rosalind Advisors, Inc.
Company:
Biofrontera Inc.
Filing Date:
2025-02-12
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Rosalind Advisors, Inc. 0 9,962,649 9.9%
SALAMON STEVEN A J 0 9,962,649 9.9%
Aharon Gil 0 9,962,649 9.9%
Rosalind Master Fund L.P. 0 9,962,649 9.9%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  This percentage is calculated based upon 8,873,932 common stock as of January 15, 2025, as reported by the Issuer on the S1 filed on January 17, 2025. However, as more fully described in Item 4, the securities reported in rows 6, 8 and 9 show the number of shares of Common Stock that would be issuable upon full conversion and exercise of such reported securities and do not give effect to such blockers. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to such blockers, is less than the number of securities reported in rows 6, 8 and 9. (6) 811,918 shares of Common Stock 6,586,629 shares of Common Stock issuable upon exercise of preferred shares 2,564,102 shares of Common Stock issuable upon exercise of convertible debt


SCHEDULE 13G



Comment for Type of Reporting Person:  (6) 811,918 shares of Common Stock 6,586,629 shares of Common Stock issuable upon exercise of preferred shares 2,564,102 shares of Common Stock issuable upon exercise of convertible debt


SCHEDULE 13G



Comment for Type of Reporting Person:  (6) 811,918 shares of Common Stock 6,586,629 shares of Common Stock issuable upon exercise of preferred shares 2,564,102 shares of Common Stock issuable upon exercise of convertible debt


SCHEDULE 13G



Comment for Type of Reporting Person:  (6) 811,918 shares of Common Stock 6,586,629 shares of Common Stock issuable upon exercise of preferred shares 2,564,102 shares of Common Stock issuable upon exercise of convertible debt


SCHEDULE 13G


 
Rosalind Advisors, Inc.
 
Signature:Steven Salamon
Name/Title:President
Date:02/12/2025
 
SALAMON STEVEN A J
 
Signature:Steven Salamon
Name/Title:Steven Salamon
Date:02/12/2025
 
Aharon Gil
 
Signature:Gil Aharon
Name/Title:Gil Aharon
Date:02/12/2025
 
Rosalind Master Fund L.P.
 
Signature:Mike McDonald
Name/Title:Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)
Date:02/12/2025